SCHEMBL10143824

SCHEMBL10143824

COc1cc(C(=O)NCC[C@H](N)C(=O)OC2CCCC2)ccc1N

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 8/20 0.51
PDE4B Q07343 8/20 0.51
PDE4C Q08493 8/20 0.51
PDE4D Q08499 8/20 0.51
MARS1 P56192 2/20 0.47
HTR4 Q13639 1/20 0.46
HRH1 P35367 1/20 0.43
CCR3 P51677 1/20 0.43
KCNH2 Q12809 1/20 0.43
EPHX2 P34913 2/20 0.43
SLC5A7 Q9GZV3 2/20 0.42
RAB9A P51151 1/20 0.42
IARS1 P41252 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10143788 1.00 PDE4A (0.51) PDE4APDE4BPDE4CPDE4DMARS1
SCHEMBL10143828 0.83 HTR4 (0.49) HTR4
SCHEMBL13261137 0.82 MCHR1 (0.47) HTR4HRH1CCR3KCNH2
SCHEMBL10144544 0.82 MCHR1 (0.47) HTR4HRH1CCR3KCNH2
SCHEMBL10144478 0.82 CACNA1B (0.49) PDE4APDE4BPDE4CPDE4DHTR4
SCHEMBL14216102 0.82 HTR4 (0.44) PDE4APDE4BPDE4CPDE4DHTR4
SCHEMBL10143826 0.78 PDE4D (0.46) PDE4APDE4BPDE4CPDE4DHRH1
SCHEMBL12427355 0.78 CXCR4 (0.67) PDE4APDE4BPDE4CPDE4DHTR4
SCHEMBL28787252 0.78 LMNA (0.64) MARS1HTR4RAB9AIARS1MEN1
SCHEMBL13175548 0.77 LMNA (0.52) MARS1HTR4HRH1CCR3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2079743-B1 PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER CHROMA THERAPEUTICS LTD (GB) 2012-01-25 EP disclosed
WO-2008050096-A1 PTERIDINE DERIVATIVES AS POLO-LIKE KINASE INHIBITORS USEFUL IN THE TREATMENT OF CANCER CHROMA THERAPEUTICS LTD. (GB) 2008-05-02 WO disclosed